Hemolytic-Uremic Syndrome clinical trials at UCSF
1 research study open to eligible people
Hemolytic-uremic syndrome is a rare kidney condition. UCSF is studying a medication called Crovalimab to see how safe and effective it is for people with this illness. The study also looks at how the body handles the drug.
Showing trials for
Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
open to eligible people ages 12 years and up
This study aims to evaluate the efficacy and safety of crovalimab in adult and adolescent participants with aHUS.
San Francisco, California and other locations
Last updated: